Clinical Trial NCT05476887
Trial
Kira pharmaceuticals – KP104-201 (NCT05476887)
Clinical trial ID
NCT05476887
Drug name
KP104
Company:
Kira pharmaceuticals
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Recruiting
Start
11/2022
Substance
Biologic
Research question
Inhibitor-naive patients, dose and efficacy assessment
Delivery method of drug
i.v.
Frequency
weekly/biweekly
Clinical trial locations
China